Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/Semaglutide-2-4-mg-demonstrates-superior-and-sustained-weight-loss-versus-placebo-and-in-addition-a-30596511/?utm_source=whatsapp&utm_medium=social&utm_campaign=share